HOLOGIC INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-11-07: Form 8-K; Period of report 2025-11-04; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2025-11-03: Form 8-K; Period of report 2025-11-03; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2025-10-21: Form 8-K; Period of report 2025-10-21; Description 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 1.01.
- 2025-09-19: Form 8-K; Period of report 2025-09-18; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2025-11-07 | 8-K | 2025-11-04 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Approval of a revised form of Restricted Stock Unit (“RSU”) Award Agreement. | ef20058329_8k.htm |
| 2025-11-03 | 8-K | 2025-11-03 | 2.02 Results of Operations and Financial Condition | 2.02 On November 3, 2025, Hologic, Inc. (“Hologic”) issued a press release announcing its financial results for the fourth quarter ended September 27, 2025. | ef20058177_8k.htm |
| 2025-10-21 | 8-K | 2025-10-21 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 5.02 In connection with the Company’s entry into the Merger Agreement, on October 21, 2025, the Company granted cash retention awards to certain of its named executive officers in the following amounts: Karleen M. Oberton: $1,000,000; Essex D. Mitchell: $500,000; and Jan Verstreken: $250,000. 8.01 On October 21, 2025, the Company issued a press release announcing entry into the Merger Agreement. | d72397d8k.htm |
| 2025-09-19 | 8-K | 2025-09-18 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 18, 2025, Hologic, Inc. (the “Company”) and Stephen P. MacMillan, the Company’s Chairman, President and Chief Executive Officer, entered into an amendment to Mr. MacMillan’s amended and restated employment agreement dated September 18, 2015, as amended, solely to extend the term of such agreement until such time as the agreement is otherwise terminated by the Company or Mr. MacMillan in accordance with its terms. | ef20055780_8k.htm |
| 2025-07-30 | 8-K | 2025-07-30 | 2.02 Results of Operations and Financial Condition | 2.02 On July 30, 2025, Hologic, Inc. issued a press release announcing its financial results for the third quarter ended June 28, 2025. | ef20052949_8k.htm |
| 2025-07-18 | 8-K | 2025-07-15 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information provided in Item 1.01 is incorporated herein by reference. | d948431d8k.htm |
| 2025-05-01 | 8-K | 2025-05-01 | 2.02 Results of Operations and Financial Condition | 2.02 On May 1, 2025, Hologic, Inc. issued a press release announcing its financial results for the second quarter ended March 29, 2025. | ef20048323_8k.htm |
| 2025-04-04 | 8-K | 2025-04-04 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 4, 2025, the Board of Directors (the “Board”) of Hologic, Inc. (the “Company”), upon the recommendation of the Company’s Nominating and Corporate Governance Committee, increased the size of the Board from eight to nine directors and appointed Wayde McMillan as a director of the Company, effective April 4, 2025. | ef20046823_8k.htm |
| 2025-03-03 | 8-K | 2025-02-26 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 On February 26, 2025, John Griffin, General Counsel, of Hologic, Inc. (“Hologic” or the “Company”) announced his intention to retire in 2025 after a distinguished career with the Company. 8.01 As a result of Mr. Griffin’s retirement, Anne Liddy, currently Vice President, Assistant General Counsel, will assume the role of General Counsel, effective May 1, 2025. | ef20044549_8-k.htm |
| 2025-02-28 | 8-K | 2025-02-26 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 The Annual Meeting of Stockholders of Hologic, Inc. (the “Company”) was held on February 26, 2025. | ef20044540_8k.htm |
| 2025-02-05 | 8-K | 2025-02-05 | 2.02 Results of Operations and Financial Condition | 2.02 On February 5, 2025, Hologic, Inc. issued a press release announcing its financial results for the first quarter ended December 28, 2024. | ef20042933_8k.htm |
| 2025-01-13 | 8-K | 2025-01-12 | 2.02 Results of Operations and Financial Condition | 2.02 On January 12, 2025, Hologic, Inc. issued a press release announcing its preliminary revenue results for the first quarter ended December 28, 2024. | ef20041439_8k.htm |
| 2025-01-10 | 8-K | 2025-01-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 6, 2025, Sally W. Crawford, a member of the Board of Directors (the “Board”), notified Hologic, Inc. (“Hologic” or the “Company”) of her decision to not stand for re-election at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”). | ef20041241_8k.htm |